The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing

N. Goire, G.B. Harnett, L.C. O'Reilly, Paul Ingram, Michael Leung, David Speers, P.E. Healy, Tim Inglis

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Web of Science)

    Fingerprint

    Dive into the research topics of 'The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing'. Together they form a unique fingerprint.

    Medicine and Dentistry